HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Serodiagnosis of hepatitis C by a recombinant hepatitis C virus protein].

Abstract
Anti-HCV prevalence was high in chronic non-A, non-B liver disease. Anti-C100-3 was detected frequently in each category of chronic non-A, non-B liver disease. Antibody to HCV core protein was detected more frequently in 95% with high titers. A significant correlation was observed between the occurrence of high titers of antibody to HCV core and serum HCV RNA positivity. In patients negative by the anti-C100-3 assay, 69% were anti-HCV-positive by the second-generation enzyme-linked immunosorbent assay and also positive by the reverse transcription-polymerase chain reaction. Thus, HCV is a major causative agent of chronic non-A, non-B hepatitis in Japan.
AuthorsN Hayashi, N Yuki, A Kasahara, H Fusamoto, T Kamada
JournalNihon rinsho. Japanese journal of clinical medicine (Nihon Rinsho) Vol. 51 Issue 2 Pg. 329-33 (Feb 1993) ISSN: 0047-1852 [Print] Japan
PMID7681883 (Publication Type: English Abstract, Journal Article, Review)
Chemical References
  • Antigens, Viral
  • C100 protein, hepatitis C virus
  • Hepatitis Antibodies
  • Hepatitis C Antibodies
  • RNA, Viral
  • Recombinant Proteins
  • Viral Core Proteins
  • Viral Nonstructural Proteins
  • Viral Proteins
  • nucleocapsid protein, Hepatitis C virus
Topics
  • Antigens, Viral
  • Genome, Viral
  • Hepacivirus (genetics, isolation & purification)
  • Hepatitis Antibodies (analysis)
  • Hepatitis C (diagnosis, microbiology)
  • Hepatitis C Antibodies
  • Humans
  • Polymerase Chain Reaction
  • RNA, Viral (analysis)
  • Recombinant Proteins (immunology)
  • Serologic Tests (methods)
  • Viral Core Proteins (immunology)
  • Viral Nonstructural Proteins (immunology)
  • Viral Proteins (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: